Document Detail


Innate immune signaling in the myelodysplastic syndromes.
MedLine Citation:
PMID:  20359630     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Myelodysplastic syndromes (MDS) are heterogeneous clonal hematologic malignancies characterized by cytopenias caused by ineffective hematopoiesis and propensity to progress to acute myeloid leukemia. Innate immunity provides immediate protection against pathogens by coordinating activation of signaling pathways in immune cells. Given the prominent role of the innate immune pathway in regulating hematopoiesis, it is not surprising that aberrant signaling of this pathway is associated with hematologic malignancies. Increased activation of the innate immune pathway may contribute to dysregulated hematopoiesis, dysplasia, and clonal expansion in myelodysplastic syndromes.
Authors:
Daniel T Starczynowski; Aly Karsan
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Hematology/oncology clinics of North America     Volume:  24     ISSN:  1558-1977     ISO Abbreviation:  Hematol. Oncol. Clin. North Am.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-02     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8709473     Medline TA:  Hematol Oncol Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  343-59     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Affiliation:
Genome Sciences Centre, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Transformation, Neoplastic / genetics
Cytokines / biosynthesis,  genetics
Gene Expression Regulation / immunology
Genes, MHC Class II
Hematopoiesis / immunology
Hematopoietic Stem Cells / cytology,  immunology
Humans
Immunity, Innate* / genetics
Inflammation / immunology
Leukemia, Myeloid, Acute / genetics,  immunology
Mice
MicroRNAs / genetics
Myelodysplastic Syndromes / genetics,  immunology*
Receptors, Immunologic / immunology
Receptors, Tumor Necrosis Factor / immunology
Toll-Like Receptors / immunology
Grant Support
ID/Acronym/Agency:
MOP 89976//Canadian Institutes of Health Research
Chemical
Reg. No./Substance:
0/Cytokines; 0/MicroRNAs; 0/Receptors, Immunologic; 0/Receptors, Tumor Necrosis Factor; 0/Toll-Like Receptors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to succes...
Next Document:  Mouse models of myelodysplastic syndromes.